Diet Programs
Keto Diet / No Carbs Diet For Parkinson Disease
Science Center

Ready to leave?
Oops ! Condition name you have entered is invalid.
You are now leaving Aposbook.com and going to an external site managed by another organization.
Please confirm your email address and try to login again.
This account has been deleted. do you want to restore it?
A verification link will be sent to within the next 2 minutes. Please click it to validate your e mail.
*If you didn't get the link, please check your spam folder
As a registered user, you can benefit from the various free tools and services that we provide.
All you need to do is log in to start discussing with others, interacting, asking questions, and sharing your point of view about the various topics.
You can also write reviews and testimonials about any natural solution you have tried and share your experience. Your feedback can be very helpful.
If you are a health expert, you can add information about any topic or suggest text edit. You can also publish content, including articles and videos, about any topic from the related library section.
Together we can help.
The Aposbook Team
A validation link will be sent to you by email. Please confirm your address to log in
*If you didn't get the link, please check your spam folder

Please log in to use this feature
Your account has been suspended because you have violated our code of conduct. If you think this was a mistake, you can contact us by email at: support@aposbook.com "Contact us" form.
Success! Thank you for your feedback. Your contribution can make a difference. Together we can help each other.
Science Center
The keto diet for Parkinson's disease has been studied as a possible dietary approach to managing Parkinson's disease symptoms and supporting brain function. Supporters suggest that ketones may provide an alternative energy source for brain cells and influence processes associated with Parkinson’s disease, including mitochondrial dysfunction, oxidative stress, and inflammation.
Some early clinical studies have reported improvements in non-motor symptoms, such as cognitive difficulties, fatigue, and sleep problems. However, other researchers emphasize that the clinical evidence remains limited and inconsistent, particularly regarding motor symptoms and disease progression.
The central discussion among experts is whether the potential benefits observed in early studies are reliable, clinically meaningful, and sustainable over time.
Supporters of the ketogenic diet believe it may help address some of the metabolic changes associated with Parkinson’s disease. One proposed mechanism involves mitochondrial dysfunction, which can impair the ability of brain cells to produce energy. By restricting carbohydrates, the keto diet encourages the body to produce ketones, which the brain can use as an alternative fuel source to glucose. Researchers suggest that this metabolic shift may help support cellular energy production and reduce some forms of oxidative stress.
Other proposed benefits involve the diet’s potential effects on inflammation and neuronal health. Experimental research suggests that ketone bodies may influence inflammatory pathways and cellular processes involved in protecting neurons. These mechanisms have led researchers to investigate whether nutritional ketosis could help manage certain symptoms of Parkinson’s disease.
However, most of the evidence supporting these biological effects comes from laboratory and animal studies, and it remains uncertain how consistently they translate into clinical benefits in people.
Some clinical findings have provided early support for this approach. In the 2018 study "Low-fat versus ketogenic diet in Parkinson's disease: A pilot randomized controlled trial," researchers compared an eight-week ketogenic diet with a low-fat diet in 47 people with Parkinson’s disease. Both groups experienced improvements in symptoms, but the ketogenic diet group showed greater improvements in several non-motor symptoms, including urinary problems, pain, fatigue, daytime sleepiness, and cognitive impairment.
The study did not find significant differences between the diets in motor symptoms, and some participants following the ketogenic diet experienced intermittent worsening of tremor or rigidity. Nevertheless, the findings suggested that ketogenic dietary therapy may have potential benefits for selected non-motor symptoms. Source
Further support came from the 2019 pilot study "Nutritional ketosis for mild cognitive impairment in Parkinson's disease: A controlled pilot trial." This study examined whether a ketogenic diet could improve cognitive performance in people with Parkinson’s-related mild cognitive impairment. Participants following the low-carbohydrate ketogenic diet showed improvements in certain measures of memory and language-related abilities compared with those following a high-carbohydrate diet.
However, the study was very small, involving only 14 participants who completed the intervention, and it did not find improvements in motor function. The findings therefore suggest a possible cognitive benefit but require confirmation in larger clinical trials. Source
Researchers who take a more cautious view emphasize that the available clinical evidence is still too limited to establish the ketogenic diet as an effective treatment for Parkinson’s disease. Although some studies have reported improvements in non-motor symptoms, findings for motor function have been inconsistent. There is also no convincing clinical evidence that the diet can slow the loss of dopamine-producing neurons or prevent the progression of the disease.
The 2022 systematic review "Ketogenic therapy for Parkinson's disease: A systematic review and synthesis without meta-analysis of animal and human trials" examined clinical and animal research on ketogenic diets and related interventions. The review included four randomized controlled trials and eight animal studies. It found that the human trials were heterogeneous and did not provide consistent evidence of improvements in motor function, cognition, or other clinical outcomes.
While animal studies showed more promising results, the authors concluded that the available human evidence was insufficient either to recommend or to rule out ketogenic therapy for Parkinson’s disease. Source
More recent clinical assessments have also highlighted these limitations. The 2026 review "Nutrition in Parkinson’s disease: what neurologists need to know," published in Practical Neurology, notes that randomized trials of ketogenic diets in Parkinson’s disease remain insufficient to establish their effectiveness. It highlights that several trials have not demonstrated clear improvements in overall symptom severity or disease progression, while some have reported adverse effects, including worsening tremor or dyskinesia.
The review also raises concerns about weight loss and nutritional deficiencies, as people with Parkinson’s disease may already be vulnerable to unintended weight loss and malnutrition. It further notes that increases in LDL cholesterol observed in some participants may have implications for cardiovascular health. Source
Practical considerations also limit the diet’s potential use. Strict carbohydrate restriction can make it difficult to maintain adequate nutritional intake, particularly for people who experience reduced appetite, swallowing difficulties, constipation, or weight loss. The diet may also require careful adjustment of protein intake and meal timing because dietary protein can affect the absorption of levodopa, a commonly used medication for Parkinson’s disease. Although the effects of ketosis on Parkinson’s medications are not yet fully understood, these nutritional and medication-related considerations make professional monitoring important.
Another major limitation is the lack of long-term research. Most clinical trials have involved relatively small groups of participants and short intervention periods. Consequently, researchers do not yet know whether any improvements in symptoms can be maintained over time, whether the diet affects the underlying progression of Parkinson’s disease, or what its long-term nutritional and cardiovascular effects may be.
Current scientific evidence suggests that the ketogenic diet may offer potential benefits for certain non-motor symptoms of Parkinson’s disease, particularly cognitive difficulties, fatigue, and other aspects of daily functioning. However, these findings come mainly from small, short-term clinical studies, and improvements in motor symptoms have not been consistently demonstrated. There is also no established evidence that the diet slows or prevents disease progression.
Experts generally recognize the need for further research rather than considering the ketogenic diet an established treatment for Parkinson’s disease. The main limitations concern the small number of clinical trials, inconsistent results, difficulties with long-term adherence, and uncertainty about nutritional and metabolic safety. More extensive and longer-term studies are needed to determine which patients, if any, may benefit and whether the observed improvements can be sustained.
At present, the ketogenic diet remains an experimental dietary approach for Parkinson’s disease rather than an established treatment. It should not replace prescribed Parkinson’s medication or other standard medical care.
AposBook Team
Published November 9, 2026
Upvote
Downvote